1. Radix Hedysari polysaccharide suppresses lipid metabolism dysfunction in a rat model of non-alcoholic fatty liver disease via adenosine monophosphate-activated protein kinase pathway activation
   WEI-MING SUN et al, 2014 CrossRef
2. Green Tea in Non-Alcoholic Fatty Liver Disease; A Double Blind Randomized Clinical Trial
   Seyed Mohammad Tabatabaee et al, 2017, Hepat Mon CrossRef
3. Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease
   Vikas Gupta, 2015, WJG CrossRef
4. Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals
   Giuseppe Della Pepa et al, 2017, Nutrients CrossRef
5. Green Tea Extract Protects Against Hepatic NFκB Activation Along The Gut-Liver Axis In Diet-Induced Obese Mice With Nonalcoholic Steatohepatitis By Reducing Endotoxin and TLR4/MyD88 Signaling
   Jinhui Li et al, 2017, The Journal of Nutritional Biochemistry CrossRef
6. Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the future
   Mehran Rahimlou, 2015, WJH CrossRef
7. Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: a clinical review
   Mohammad Baghernya et al, 2017, Pharmacological Research CrossRef
8. Chemopreventive Potential of Green Tea Catechins in Hepatocellular Carcinoma
   Masahito Shimizu et al, 2015, IJMS CrossRef
9. Comparative studies on the hypolipidemic, antioxidant and hepatoprotective activities of catechin-enriched green and oolong tea in a double-blind clinical trial
   Kamesh Venkatakrishnan et al, 2018, Food Funct. CrossRef
10. Nrf2 signaling pathway: Pivotal roles in inflammation.
    Syed Minhaj Uddin Ahmed et al, 2017, Biochim Biophys Acta Mol Basis Dis CrossRef
11. The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases
    Sha Li et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
12. Protection by different classes of dietary polyphenols against palmitic acid-induced steatosis, nitro-oxidative stress and endoplasmic reticulum stress in HepG2 hepatocytes
    Hossein Rafiei et al, 2018, Journal of Functional Foods CrossRef
13. The safety of green tea and green tea extracts consumption in adults – Results of a systematic review
    Jiang Hu et al, 2018, Regulatory Toxicology and Pharmacology CrossRef
14. An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
    Priscila Silva Figueiredo et al, 2018, Molecules CrossRef
15. Scientific opinion on the safety of green tea catechins.
    null null et al, 2018, EFSA J CrossRef
16. Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta-analysis of clinical trials
    Fariborz Mansour-Ghanaei et al, 2018, Phytotherapy Research CrossRef
17. null
    Louis H. S. Lau et al, 2018 CrossRef
18. Dietary Green Tea Extract Prior to Spinal Cord Injury Prevents Hepatic Iron Overload but does not Improve Chronic Hepatic and Spinal Cord Pathology in Rats
    Matthew Goodus et al, 2018, Journal of Neurotrauma CrossRef
19. Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
    Brandon Perumpail et al, 2018, Diseases CrossRef
20. Ginsenosides, catechins, quercetin and gut microbiota: Current evidence of challenging interactions
    Rosaria Santangelo et al, 2018, Food and Chemical Toxicology CrossRef
21. Effect of aqueous extract of Allium saralicum R.M. Fritsch on fatty liver induced by high-fat diet in Wistar rats
    Rohallah Moradi et al, 2018, Comp Clin Pathol CrossRef
22. null
    Cindy X. Cai et al, 2019 CrossRef
23. Polyphenol intakes and risk of impaired lipid profile, elevated hepatic enzymes and nonalcoholic fatty liver disease
    Mehrnaz Nikkhah-Bodaghi et al, 2019, Nutrition & Food Science CrossRef
24. Hepatoprotective and cytotoxicity properties of aqueous extract of Glycyrrhiza glabra in Wistar rats fed with high-fat diet
    Samaneh Goorani et al, 2019, Comp Clin Pathol CrossRef
25. Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease
    Jie Zhou et al, 2019, J. Agric. Food Chem. CrossRef
26. Non-alcoholic fatty liver disease: need for a balanced nutritional source
    Jayagopalan Veena et al, 2014, Br J Nutr CrossRef
27. null
    Arpita Basu et al, 2015 CrossRef
28. Risk Factors Associated With Non-Alcoholic Fatty Liver Disease in Indians: A Case–Control Study
    Shivaram P. Singh et al, 2015, Journal of Clinical and Experimental Hepatology CrossRef
29. Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.
    Federico Salomone et al, 2016, Liver Int CrossRef
30. Non-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids
    Masoumeh Akhlaghi, 2016, Phytother. Res. CrossRef
31. null
    Arpita Basu et al, 2016 CrossRef
32. null
    Arpita Basu et al, 2016 CrossRef
33. Green tea extract treatment reduces NFκB activation in mice with diet-induced nonalcoholic steatohepatitis by lowering TNFR1 and TLR4 expression and ligand availability
    Jinhui Li et al, 2017, The Journal of Nutritional Biochemistry CrossRef
34. null
    Arpita Basu et al, 2017 CrossRef
35. Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study
    Louise J.M. Alferink et al, 2017, Journal of Hepatology CrossRef
36. Daily tea drinking is not associated with newly diagnosed non-alcoholic fatty liver disease in Chinese adults: the Tianjin chronic low-grade systemic inflammation and health cohort study
    Yang Xia et al, 2019, Nutr J CrossRef
37. Mitigation of nonalcoholic fatty liver disease in high-fat-fed mice by the combination of decaffeinated green tea extract and voluntary exercise
    Weslie Y. Khoo et al, 2020, The Journal of Nutritional Biochemistry CrossRef
38. Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo
    Chen Liang et al, 2020, Pharmacological Research CrossRef
39. null
    Devaraj Ezhilarasan, 2020 CrossRef
40. Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta‐analysis of randomized clinical trials
    Marzieh Mahmoodi et al, 2020, Phytotherapy Research CrossRef
41. Botanical Medicine and Phytochemicals in Healthy Aging and Longevity—Part 2
    Khara Lucius, 2020, Alternative and Complementary Therapies CrossRef
42. Bioactive compounds and inflammation: an overview
    Giovanna Cavanha Corsi et al, 2020, Nutrire CrossRef
43. Interaction of Polyphenols as Antioxidant and Anti-Inflammatory Compounds in Brain–Liver–Gut Axis
    Amritpal Singh et al, 2020, Antioxidants CrossRef
44. Mixtures of Tea and Citrus maxima (pomelo) Alleviate Lipid Deposition in HepG2 Cells Through the AMPK/ACC Signaling Pathway
    Ran An et al, 2020, Journal of Medicinal Food CrossRef
45. Efficacy of Dietary Supplements to Reduce Liver Fat
    Brittanie Kilchoer et al, 2020, Nutrients CrossRef
46. Ethyl Acetate Fraction of Amomum xanthioides Ameliorates Nonalcoholic Fatty Liver Disease in a High-Fat Diet Mouse Model
    Hwi-Jin Im et al, 2020, Nutrients CrossRef
47. Higher flavonoid intake is associated with a lower progression risk of non-alcoholic fatty liver disease in adults: a prospective study
    Qing-wei Zhong et al, 2020, Br J Nutr CrossRef
48. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling
    Samukelisiwe C. Shabalala et al, 2020, Biomedicine & Pharmacotherapy CrossRef
49. Medicinal plants and bioactive natural compounds as inhibitors of HMG‐CoA reductase: A literature review
    Atena Mahdavi et al, 2020, BioFactors CrossRef
50. Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
    Rosa Lombardi et al, 2020, IJMS CrossRef
51. (−)-Epigallocatechin-3-O-gallate at a high concentration may induce lipolysis via ATP consumption by activation of stress defense mechanisms
    Satoki Suihara et al, 2021 CrossRef
52. null
    Venkateish V. Palanisamy et al, 2021 CrossRef
53. Effects of several tea extracts on nonalcoholic fatty liver disease in mice fed with a high‐fat diet
    Qian‐Qian Mao et al, 2021, Food Sci Nutr CrossRef
54. null
    Alper Sonmez et al, 2021 CrossRef
55. null
    Fateme Gharibpour et al, 2021 CrossRef
56. null
    Atena Mahdavi et al, 2021 CrossRef
57. Beverages and Non-alcoholic fatty liver disease (NAFLD): Think before you drink
    Jyoti Chhimwal et al, 2021, Clinical Nutrition CrossRef
58. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double‐blind clinical trial
    Reyhaneh Darvish Damavandi et al, 2021, Phytotherapy Research CrossRef
59. Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism
    Guoyi Tang et al, 2021, Antioxidants CrossRef
60. Effects of Nigella sativa, Camellia sinensis, and Allium sativum as Food Additives on Metabolic Disorders, a Literature Review
    Akbar Anaeigoudari et al, 2021, Front. Pharmacol. CrossRef
61. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
    Natalia Vallianou et al, 2021, Biomolecules CrossRef
62. Regulation of Apolipoprotein B by Natural Products and Nutraceuticals: A Comprehensive Review
    Mohammad Bagherniya et al, 2021, CMC CrossRef
63. null
    Bhat M. Aalim et al, 2022 CrossRef
64. Epigallocatechin gallate ameliorates tetrahydrochloride-induced liver toxicity in rats via inhibition of TGFβ / p-ERK/p-Smad1/2 signaling, antioxidant, anti-inflammatory activity
    Gomaa Mostafa-Hedeab et al, 2022, Saudi Pharmaceutical Journal CrossRef
65. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Kailin Yang et al, 2022, Front. Immunol. CrossRef
66. null
    Theano Stoikidou et al, 2023 CrossRef
67. Effect of portulaca oleracea (purslane) extract on inflammatory factors in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial
    Reyhaneh Darvish Damavandi et al, 2023, Journal of Functional Foods CrossRef
68. Epigallocatechin gallate alleviates high-fat diet-induced hepatic lipotoxicity by targeting mitochondrial ROS-mediated ferroptosis
    Shi-Bin Ding et al, 2023, Front. Pharmacol. CrossRef
69. Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease
    Mengyao Zhao et al, 2021, Pharmacological Research CrossRef
70. Therapeutic potential of bioactive phytoconstituents found in fruits in the treatment of non-alcoholic fatty liver disease: A comprehensive review
    Manash Pratim Pathak et al, 2023, Heliyon CrossRef
71. The association of dietary phytochemical index and nonalcoholic fatty liver disease
    Bijan Ahmadi et al, 2023, Food Science & Nutrition CrossRef